Patent · US Active

Modulation of T cell signaling threshold and T cell sensitivity to antigens

US7803784B2 · kind B2 · utility

4Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 24, 2007
Grant dateSep 28, 2010
Priority date
Expiry dateOct 24, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

MicroRNAs (miRNAs) are a diverse and abundant class of ˜22-nucleotide (nt) endogenous regulatory RNAs that play a variety of roles in animal cells by controlling gene expression at the posttranscriptional level. Increased miR-181a expression in mature T cells is shown to cause a marked increase in T cell activation and augments T cell sensitivity to peptide antigens. Moreover, T cell blasts with higher miR-181a expression become reactive to antagonists. The effects of miR-181a on antigen discrimination are in part achieved by dampening the expression of multiple negative regulators in the T cell receptor (TCR) signaling pathway, including PTPN22 and the dual specificity phosphatases DUSP5 and DUSP6. This results in a reduction in the TCR signaling threshold, thus quantitatively and qualitatively enhancing T cell sensitivity to antigens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.